BMI < 18.5 (n = 121) (2%) | BMI 18.5–24.9 (n = 2448) (38%) | BMI 25–29.9 (n = 2633) (41%) | BMI > 30 (n = 1234) (19%) | p-value* | |
---|---|---|---|---|---|
Age (years), mean (SD) | 68.9 ± 11.5 | 68.5 ± 11.0 | 68.4 ± 9.7 | 67.5 ± 8.8 | 0.012 |
Sex, n (%) | < 0.001 | ||||
Male | 34 (28.1) | 1323 (54.0) | 1709 (64.9) | 682 (55.3) | |
Female | 87 (71.9) | 1125 (46.0) | 924 (35.1) | 552 (44.7) | |
Tumor location, n (%) | < 0.001 | ||||
Right colon | 51 (43.6) | 770 (31.8) | 779 (29.8) | 377 (30.7) | |
Left colon | 32 (27.4) | 845 (34.9) | 942 (36.1) | 507 (41.3) | |
Rectum | 34 (29.1) | 805 (33.3) | 891 (34.1) | 344 (28.0) | |
Tumor differentiation, n (%) | < 0.001 | ||||
Good/moderate | 77 (63.6) | 1781 (72.8) | 2058 (78.2) | 968 (78.4) | |
Poor/undifferentiated | 15 (12.4) | 225 (9.2) | 210 (8.0) | 107 (8.7) | |
Missing | 29 (24.0) | 442 (18.1) | 365 (13.9) | 159 (12.9) | |
Tumor histology | 0.910 | ||||
Adenocarcinoma | 110 (90.9) | 2238 (91.4) | 2404 (91.3) | 1113 (90.2) | |
Mucinous adenocarcinoma | 9 (7.4) | 184 (7.5) | 201 (7.6) | 105 (8.5) | |
Signet ring cell carcinoma | 2 (1.7) | 26 (1.1) | 28 (1.1) | 16 (1.3) | |
Synchronous PM, n (%) | 0.005 | ||||
Yes | 9 (7.4) | 135 (5.5) | 108 (4.1) | 41 (3.3) | |
No | 112 (92.6) | 2313 (94.5) | 2525 (95.9) | 1193 (96.7) | |
Synchronous systemic metastases, n (%) | < 0.001 | ||||
Yes | 30 (24.8) | 517 (21.1) | 415 (15.8) | 150 (12.2) | |
No | 91 (75.2) | 1931 (78.9) | 2218 (84.2) | 1084 (87.8) | |
Tumor stage, n (%) | < 0.001 | ||||
T0–2 | 17 (15.3) | 699 (30.2) | 929 (35.3) | 458 (37.1) | |
T3 | 70 (63.1) | 1191 (51.4) | 1278 (48.5) | 600 (48.6) | |
T4 | 24 (21.6) | 425 (17.4) | 327 (12.4) | 139 (11.3) | |
Missing data | 10 (8.3) | 133 (5.4) | 99 (3.8) | 37 (3.0) | |
Nodal stage, n (%) | 0.238 | ||||
N0 | 53 (43.8) | 1019 (41.6) | 1155 (43.9) | 560 (45.4) | |
N1 | 39 (32.2) | 826 (33.7) | 861 (32.7) | 400 (32.4) | |
N2 | 20 (16.5) | 521 (21.3) | 512 (19.4) | 228 (18.5) | |
Missing data | 9 (7.4) | 82 (3.3) | 105 (4.0) | 46 (3.7) |